Please login to the form below

Not currently logged in
Email:
Password:

Glassia

This page shows the latest Glassia news and features for those working in and with pharma, biotech and healthcare.

Shire receives FDA nod for self-infusion of Glassia

Shire receives FDA nod for self-infusion of Glassia

Shire receives FDA nod for self-infusion of Glassia. The company has also struck a deal with Pfizer to expand its GI portfolio. ... Shire's emphysema therapy Glassia has received FDA approval for an expanded label, marking the first time that patients

Latest news

  • Scratching the surface

    UK. Alpha-1 proteinase inhibitor. Glassia (Baxter International). Overt hepatic encephalopathy (HE) recurrence.

  • Biologics buoyant

    52 . Kamada/Baxter. Glassia (liquid Alpha-1 Antitrypsin; AAT) – AAT deficiency (US, Canada, Australia and New Zealand).

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics